Several components of this system, including IGF-1, are decreased in the skeletal muscle of sALS patients, while the IGF-1 receptor β subunit (IGF-1Rβ) was significantly increased, and the expression of activated AKT was downregulated in human ALS skeletal muscle [135,139]. The gene discussed is AKT1; the disease is amyotrophic lateral sclerosis.